{"id":"https://openalex.org/W82415120","doi":"https://doi.org/10.1007/978-1-4612-4508-7_56","title":"Antibodies Against EBNA-1 Derived Synthetic Peptide in Various Patient Groups","display_name":"Antibodies Against EBNA-1 Derived Synthetic Peptide in Various Patient Groups","publication_year":1989,"publication_date":"1989-01-01","ids":{"openalex":"https://openalex.org/W82415120","doi":"https://doi.org/10.1007/978-1-4612-4508-7_56","mag":"82415120"},"language":"en","primary_location":{"id":"doi:10.1007/978-1-4612-4508-7_56","doi":"https://doi.org/10.1007/978-1-4612-4508-7_56","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-1-4612-4508-7_56","pdf_url":null,"source":{"id":"https://openalex.org/S4306463399","display_name":"Humana Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310315801","host_organization_name":"Humana Press","host_organization_lineage":["https://openalex.org/P4310315801","https://openalex.org/P4310319900"],"host_organization_lineage_names":["Humana Press","Springer Science+Business Media"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epstein-Barr Virus and Human Disease \u2022 1988","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W1567685376","display_name":"Epstein-Barr Virus and Human Disease \u2022 1988"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088610311","display_name":"Jaroslav Roubal I","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jaroslav Roubal","raw_affiliation_strings":["Inst. Sera & Vaccines, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inst. Sera & Vaccines, Czech Republic","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031342042","display_name":"Pavel Sova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pavel Sova","raw_affiliation_strings":["Inst. Sera & Vaccines, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inst. Sera & Vaccines, Czech Republic","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052292378","display_name":"Eva Ham\u0161\u00edkov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eva Ham\u0161\u00edkov\u00e1","raw_affiliation_strings":["Inst. Sera & Vaccines, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inst. Sera & Vaccines, Czech Republic","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006798993","display_name":"Viktor Krch\u0148\u00e1k","orcid":"https://orcid.org/0000-0001-5688-4069","observed_orcids":["https://orcid.org/0000-0001-5688-4069"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Viktor Krchn\u00e1k","raw_affiliation_strings":["Pharmaceuticals Prague, Prague, Czechoslovakia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceuticals Prague, Prague, Czechoslovakia","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.11354309,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"375","last_page":"378"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.9545999765396118,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.9545999765396118,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.010200000368058681,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.009499999694526196,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ebna1","display_name":"EBNA1","score":0.9589999914169312},{"id":"https://openalex.org/keywords/epstein-barr-virus","display_name":"Epstein-Barr virus","score":0.9890000224113464},{"id":"https://openalex.org/keywords/synthetic-peptides","display_name":"synthetic peptides","score":0.7210000157356262},{"id":"https://openalex.org/keywords/antibody-detection","display_name":"antibody detection","score":0.6729999780654907},{"id":"https://openalex.org/keywords/elisa","display_name":"ELISA","score":0.9330000281333923},{"id":"https://openalex.org/keywords/bsa-conjugate","display_name":"BSA conjugate","score":0.7440000176429749},{"id":"https://openalex.org/keywords/glutaraldehyde-coupling","display_name":"glutaraldehyde coupling","score":0.7149999737739563},{"id":"https://openalex.org/keywords/serological-diagnosis","display_name":"serological diagnosis","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.7679532170295715},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.730685293674469},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7033934593200684},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6903687119483948},{"id":"https://openalex.org/C2778236600","wikidata":"https://www.wikidata.org/wiki/Q592324","display_name":"Immunofluorescence","level":3,"score":0.5847378373146057},{"id":"https://openalex.org/C2777529624","wikidata":"https://www.wikidata.org/wiki/Q416475","display_name":"Glutaraldehyde","level":2,"score":0.5719099640846252},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5347505807876587},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4646904468536377},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.37210941314697266},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3447036147117615},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2065342366695404},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1809740960597992},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.09803581237792969},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.06480661034584045},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/978-1-4612-4508-7_56","doi":"https://doi.org/10.1007/978-1-4612-4508-7_56","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-1-4612-4508-7_56","pdf_url":null,"source":{"id":"https://openalex.org/S4306463399","display_name":"Humana Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310315801","host_organization_name":"Humana Press","host_organization_lineage":["https://openalex.org/P4310315801","https://openalex.org/P4310319900"],"host_organization_lineage_names":["Humana Press","Springer Science+Business Media"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epstein-Barr Virus and Human Disease \u2022 1988","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W1616010712","https://openalex.org/W2319468185"],"related_works":["https://openalex.org/W1973242169","https://openalex.org/W588163558","https://openalex.org/W2363045905","https://openalex.org/W2045324771","https://openalex.org/W1974054017","https://openalex.org/W2005806320","https://openalex.org/W2495671553","https://openalex.org/W211821945","https://openalex.org/W2157339633","https://openalex.org/W1616010712"],"abstract_inverted_index":{"We":[0],"developed":[1],"an":[2],"ELISA":[3],"test":[4,29],"for":[5,63],"the":[6,34,65,82,99,106,112],"detection":[7],"of":[8,36,40,58,68,79],"antibodies":[9,32],"against":[10,33],"EBV":[11,41,69],"determined":[12],"nuclear":[13,38],"antigen":[14],"1":[15],"CEBNA-1)":[16],"using":[17],"a":[18,51,87],"synthetic":[19,45],"peptide.":[20],"Its":[21],"diagnostic":[22],"potency":[23],"was":[24,73,84],"compared":[25],"with":[26],"anticomplement":[27],"immunofluorescence":[28],"CACIF)":[30],"detecting":[31],"complex":[35],"several":[37],"antigens":[39],"CEBNA":[42],"complex).":[43],"The":[44,71],"peptide,":[46],"designated":[47],"p62":[48],"(1),":[49],"represented":[50],"gly":[52],"and":[53,81,96,105],"ala":[54],"rich":[55],"antigenic":[56],"determinant":[57],"EBNA-1":[59],"which":[60],"is":[61,103],"coded":[62],"by":[64,77,94,98],"IR3":[66],"repeat":[67],"genome.":[70],"peptide":[72],"conjugated":[74],"to":[75],"BSA":[76],"means":[78],"glutaraldehyde":[80],"conjugate":[83],"used":[85],"at":[86],"concentration":[88],"2ug/well.":[89],"These":[90],"keywords":[91,107],"were":[92],"added":[93],"machine":[95],"not":[97],"authors.":[100],"This":[101],"process":[102],"experimental":[104],"may":[108],"be":[109],"updated":[110],"as":[111],"learning":[113],"algorithm":[114],"improves.":[115]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}